Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features
Maria Antonia De Francesco, Claudio Poiesi, Franco Gargiulo, Carlo Bonfanti, P. Pollara, Simona Fiorentini, Francesca Caccuri, Valentina Carta, Lucia Mangeri, Simone Pellizzeri, Damiano Rizzoni, Paolo Malerba, Massimo Salvetti, María Lorenza Muiesan, Federico Alberici, Francesco Scolari, Andrea Pilotto, Alessandro Padovani, Michela Bezzi, Raffaella Chiappini, Chiara Ricci, Maurizio Castellano, Marialma Berlendis, Giulia Savio, Giovanni Montani, Maurizio Ronconi, Sergio Bove, Emanuele Focà, Lina Rachele Tomasoni, Francesco Castelli, Angelo Rossini, Riccardo M. Inciardi, Marco Metra, Arnaldo Caruso
Topics & Concepts
CoinfectionMycoplasma pneumoniaeMycoplasmaMedicineScopusChlamydophila pneumoniaeCoronavirus disease 2019 (COVID-19)ChlamydiaVirologyInternal medicineMEDLINEImmunologyMicrobiologyBiologyPneumoniaHuman immunodeficiency virus (HIV)ChlamydiaceaeBiochemistryDiseaseInfectious disease (medical specialty)Pneumonia and Respiratory InfectionsRespiratory viral infections researchCOVID-19 Impact on Reproduction